|
Introduction DNA double-strand breaks (DSBs) are highly toxic lesions that, if unrepaired or repaired incorrectly, compromise genome stability and can lead to cancer (Khanna and Jackson, 2001). To deal with DSBs and other lesions in DNA, cells have evolved a network of responses, referred to as the DNA-damage response (DDR). A hallmark of the DDR is the recruitment of proteins to damaged chromatin regions; some of these factors engage in DNA repair, whereas others trigger DNA-damage checkpoints that delay cell-cycle progression and coordinate repair processes (Zhou and Elledge, 2000; Rouse and Jackson, 2002). Some DDR factors, such as MDC1 and 53BP1, accumulate in large nuclear aggregates that appear as IR-induced nuclear foci (IRIF) by fluorescence microscopy (Schultz et al, 2000; Goldberg et al, 2003; Stewart et al, 2003), and accumulating evidence suggests that IRIF are required for accurate and coordinated DSB repair in the context of chromatin (Fernandez-Capetillo et al, 2004).
A key factor of IRIF formation in mammalian cells is the histone H2A variant H2AX, a component of the nucleosome core that comprises 5–20% of total cellular H2A in higher organisms (Rogakou et al, 1998; Fernandez-Capetillo et al, 2003, 2004). H2AX is phosphorylated on serine 139 near its carboxyl terminus (the phosphorylated form is referred to as H2AX) in extended regions of chromatin flanking DSBs (Rogakou et al, 1998), and this response is mediated by ataxia telangiectasia mutated (ATM) and DNA-dependent protein kinase catalytic subunit (DNA-PKcs), two members of the phosphoinositide 3-kinase-related protein kinase (PIKK) family (Stiff et al, 2004; Falck et al, 2005). Rapidly after H2AX phosphorylation, the DNA-damage mediator protein, MDC1/NFBD1, is recruited to damage sites by its tandem BRCA1 carboxy-terminal (BRCT) domain, specifically interacting with the H2AX C-terminal phospho-epitope (Lukas et al, 2004; Stucki et al, 2005). The yeast Saccharomyces cerevisiae lacks a H2AX variant, but instead, PIKK-family proteins phosphorylate the C-terminus of histone H2A in response to DNA damage, and this phosphorylation spreads about 25 kb to each side of a HO-induced DSB and is absent in the immediate vicinity of the break (Shroff et al, 2004). By contrast, H2AX spreading in mammals has been estimated to occur over regions up to 3 Mb adjacent to DSBs, as measured by two-dimensional gel electrophoresis and immunofluorescence microscopy studies (Rogakou et al, 1998, 1999). The underlying similarities and differences between the mechanisms of chromatin spreading of phospho-H2AX/H2A in yeast and mammals, however, are currently unknown. Through the use of fluorescence microscopy experiments, it has been shown that, in addition to MDC1, other DDR factors such as 53BP1, the Mre11-Rad50-Nbs1 (MRN) complex, ATM and BRCA1 also spread over long distances together with H2AX (for example, Bekker-Jensen et al, 2006). Mainly due to the lack of a suitable system to induce site-specific DSBs in mammals, however, molecular data about the spreading distances and molecular architecture of DSB-modified nucleosomal fibres in higher eukaryotes are not yet available.
Telomeres are specialised structures at the ends of linear chromosomes, and in most organisms they consist of repetitive short-sequence elements that bind proteins to form a complex termed Shelterin that sequesters the telomeric DNA and prevents it being recognised as DNA damage (D'Adda Di Fagagna et al, 2004; de Lange, 2005). To counteract gradual telomere shortening caused by the inability of the standard DNA replication apparatus to fully replicate chromosomal ends, the ribonucleoprotein complex, telomerase, adds additional telomeric repeats to chromosomal termini in a regulated fashion. However, whereas this occurs in human stem cells and in the germ line, most somatic human cells lack sufficient telomerase to maintain telomere length. Consequently, telomeres gradually shorten upon the continual passage of somatic human cells (Martens et al, 2000), ultimately leading to replicative senescence, the irreversible loss of replicative capacity occurring upon extended culture (Hayflick and Moorhead, 1961). Significantly, age-related diseases and premature ageing syndromes are sometimes characterised by short telomeres (Blasco, 2005).
Notably, the major hallmarks of a DDR are observed in cells experiencing replicative senescence, with H2AX, MDC1, 53BP1 and other DDR factors accumulating on the critically shortened telomeres in such cells or in cells which have entered senescence as a result of artificial telomere uncapping (d'Adda di Fagagna et al, 2003; Takai et al, 2003; Shay and Wright, 2004; Zou et al, 2004; Hockemeyer et al, 2005). Under these conditions, cell-cycle arrest is triggered through a signalling cascade involving the DDR signalling proteins ATM, p53 and p21 (Herbig et al, 2004). Taken together, these findings suggest that in late-passage cultures of primary human cells, it is the subset of very short telomeres—devoid of most of their telomeric repeat sequences—which triggers DNA-damage foci formation and terminal cell-cycle arrest.
Here, by using the technique of ChIP-chip (chromatin immunoprecipitation) in combination with array-CGH (comparative genome hybridisation), we have analysed human senescent fibroblasts to study the molecular changes in chromatin that result from a DDR at uncapped telomeres. Our high-resolution analyses with whole-genome tile-path arrays provide precise data about the spreading distances in mammalian cells for various DDR factors, indicating that modification of the nucleosomal fibre flanking DSBs is not homogenous. We discuss the relevance of our findings in relation to telomere uncapping in senescence and in regard to the factors governing H2AX and DDR factor distribution in senescent and proliferating cells.
Results DNA-damage foci in senescent cells are ATM dependent, dynamic and reversible
To characterise the DDR as part of the senescent programme in the human fibroblasts used in this study, we first quantified DNA-damage foci in proliferating and senescent BJ fibroblasts. Whereas 25% of proliferating BJ cells displayed colocalising foci for H2AX and 53BP1, most of these cells only had one prominent focus and very few had two or more foci (Figure 1A). By contrast, more than 90% of senescent BJ cells exhibited prominent DNA-damage foci, and most of these cells had between two and six foci per cell (Figure 1A). Although we cannot exclude clustering of telomeres and the calculated numbers might therefore be too conservative, these observations support the hypothesis that only relatively few uncapped telomeres are sufficient to initiate senescence (Zou et al, 2004). When we treated senescent cells for 24 h with potent small-molecule inhibitors of the ATM protein kinase (Hickson et al, 2004)—the major kinase responsible for DSB signalling—around 75% of senescent cells lost their DNA-damage foci and the remaining foci were small and difficult to detect (Figure 1B; senescent cells treated with the ATM inhibitor did not incorporate BrdU, indicating that inhibition of ATM was not sufficient to trigger cell-cycle re-entry—data not shown). Thus, as concluded previously by Herbig et al (2004), uncapped telomeres signal mainly through ATM. After removal of the ATM inhibitor for a further 48 h, senescent cells regained their foci, demonstrating that the DDR in senescent cells is continuously active, dynamic and reversible (Figure 1B). As these phenomena were also observed for cells that had been senescent in culture for more than 6 months (data not shown), we conclude that under these conditions, uncapped telomeres represent unrepairable DSBs that engage and maintain constantly active DNA-damage signalling.
|
|
To validate the above results obtained with the ChIP-chip analyses, we amplified the ChIP samples by real-time PCR with primer pairs covering the subtelomeric region of telomeres 6p and 12p (Figure 6B). The enrichment of H2AX (IP versus input) obtained with real-time PCR (yellow open squares) matched very well to the data produced from the ChIP-chip studies (black squares), showing the reproducibility of our results with two different approaches.
Finally, to further define the spreading distances revealed by the above analyses, we generated data sets by averaging 100 neighbouring points (red line in Figure 6A), and determined the spreading boundary for selected telomeres as the transition point, where the log2 ratio was higher than the background scattering (tabulated in Figure 6C). The spreading distances thus obtained varied from 63 to 568 kb, with an average spreading distance of 280 kb (for telomere 6, there were also additional peaks observed between 0.7 and 1.5 Mb). These data therefore confirmed the conclusions drawn from the data in Figure 5, and reveal that the spreading distance of H2AX in mammals is considerably longer than for H2A phosphorylation in S. cerevisiae, but is shorter than previous estimations made with human cell lines (Rogakou et al, 1998).
Discussion Use of ChIP-chip to study DSB-induced chromatin alterations in mammalian cells
In this study, we applied a ChIP-chip approach to investigate the molecular consequences of DNA damage on chromatin structure. For our analyses, we employed senescent primary cells, which display a high degree of genome stability, but possess uncapped telomeres that initiate a DDR, making this a good model system to study molecular events triggered by DSBs. This study of senescent cells has revealed insights not only into how the DDR impacts on chromatin, but also into telomere-initiated senescence with respect to individual telomeres.
Spreading of mammalian DDR factors along chromatin fibres
We used a custom telomeric array, comprised of PCR products, that covers four telomeres at 10 kb resolution as well as a custom-designed oligonucleotide array (NimbleGen Systems Inc.) covering 3 Mb of most telomeres at a mean resolution of 230 bp. Thus, limited by the average fragment size of the sonicated chromatin, we were able to measure H2AX at most human telomeres at a resolution of about 1 kb. Perhaps surprisingly, the spreading distances observed were not uniform, but ranged from 60 to 570 kb for the different subtelomeric regions analysed. These spreading distances are therefore considerably longer than those documented in yeast, where phosphorylated H2A spreads to approximately 25 kb to each side of a HO-induced DSB (Shroff et al, 2004). A possible explanation for this difference is that H2AX spreading in mammalian cells is promoted and amplified by the H2AX-binding factor MDC1, which has no clear counterpart in yeast (Stucki et al, 2005; Lou et al, 2006; Stucki and Jackson, 2006). Alternatively or in addition, it is possible that the number of phosphorylated H2AX molecules produced in response to a DSB is similar in yeast and mammals, but that not every H2AX molecule becomes phosphorylated (Pilch et al, 2003). Because signalling events emanating from uncapped telomeres bear all the major hallmarks of a bona fide DDR, and as telomere-induced foci are likely to represent unrepairable DSBs, we anticipate that the spreading distances we have obtained will be in the same range when DNA damage takes place at other sites in the mammalian genome. Notably, however, the values we obtained are considerably shorter than those estimated for mammalian H2AX from two-dimensional electrophoresis data, which suggested that regions up to 3 106 kb are produced in various human cell lines (Rogakou et al, 1998). Further work will be required to determine whether this discrepancy reflects real differences between H2AX spreading in subtelomeric regions and interstitial chromosomal loci or is due to inaccuracies in previous estimates—for example because of technical limitations or possibly due to variations in H2AX distribution throughout the genome (see below). In regard to these issues, we note that one exception in our studies was telomere 6p, where enrichment of H2AX was observed up to 1.5 Mb. This suggests that, at least in some cases, H2AX can be generated well over 1 Mb away from the initiating DNA lesion, although at this time we are unable to exclude the possibility that this might instead reflect the occurrence of multiple, alternative sites for chromosomal DSB generation in the 6p subtelomeric region.
If H2AX phosphorylation can occur over hundreds of kilobases of chromatin, what then prevents H2AX spreading throughout the damaged chromosome and why is it that spreading takes place to different extents in different subtelomeric regions? Although our analyses have so far been unable to identify any clear physical or sequence-composition signatures that might correspond to the boundary regions of H2AX spreading, it is possible that such features do exist. Alternatively, the extent of spreading could be affected by the initial chromatin structure of the region in question. Notably, a recent study analysed H2AX distribution patterns with high-resolution confocal microscopy and concluded that H2AX is not distributed randomly throughout bulk chromatin, but is rather deposited in distinct regions of the genome and absent from others (Bewersdorf et al, 2006). It will therefore be interesting to compare the H2AX distribution at telomeres 5p, 6p, 9q and 11q and see whether any variations correlate with the different extents of H2AX spreading we observed. In this regard, it is tempting to speculate that the multiple subtelomeric peaks of H2AX that we have observed might reflect the existence of relatively H2AX-dense and H2AX-poor regions of the genome. It is also possible that spreading could be influenced by the histone variant H2AZ, which is distributed nonrandomly throughout the yeast genome (Raisner et al, 2005; Zhang et al, 2005). Alternatively, it is possible that H2AX spreading is influenced by higher-order chromatin structure, an issue of particular relevance to our work, because mammalian subtelomeric regions display features of constitutive heterochromatin (Gonzalo et al, 2006). ChIP-chip studies with antibodies against heterochromatin components and/or with H2AX-specific antibodies, may shed light on these issues.
Molecular architecture of the DNA-damage modified nucleosomal fibre
When we used arrays covering four telomeres to compare the spreading of H2AX with that of the DDR factors 53BP1 and MDC1, we found that the spreading distances were very similar. This strongly suggests that these factors are in close proximity on nucleosomal fibres flanking DSBs. Whereas the H2AX C-terminus was shown to interact with the tandem-BRCT domain of MDC1 with high affinity, it is at present not clear what precisely controls the association of 53BP1 with damaged chromatin. Whereas retention of 53BP1 in DNA-damage foci requires H2AX and MDC1 (Celeste et al, 2002; Ward et al, 2003; Bekker-Jensen et al, 2005), it is clear that methylated lysine residues in histone proteins play a major role in 53BP1 recruitment to DNA-damage sites (Huyen et al, 2004; Botuyan et al, 2006). Whether the link between H2AX/MDC1 and 53BP1 in chromatin flanking DSBs is direct or indirect is, therefore, yet to be established.
Cell line specific telomere shortening correlates with signalling of uncapped telomeres
By comparing the telomeres enriched for H2AX and 53BP1 in BJ and MRC5 fibroblasts, we observed not only a difference in the subset of uncapped telomeres that signals in the two cell lines, but also observed a correlation of these subsets with individual telomere lengths. Therefore, these findings provide support for a model in which only the shortest telomeres become uncapped in fibroblasts undergoing replicative senescence, and also link telomere attrition to the DDR at the level of individual chromosomes. Our data stand in agreement with a study that analysed selected telomeres in BJ fibroblasts (Zou et al, 2004). Notably, this study reported telomere 6p to be short in pre-senescent BJ cells, providing support for our finding that this telomere strongly triggers DDR signalling in proliferating BJ cell populations. The observation that the telomere lengths and the subset of signalling telomeres were different in BJ and MRC5 cells was not surprising as variations of telomere length between individuals and between maternal and paternal telomeres have been reported previously (Londono-Vallejo et al, 2001; Graakjaer et al, 2003). It is also possible that the observed differences might be caused by endogenous cellular stress, which affects the speed of telomere attrition (Lorenz et al, 2001; Von Zglinicki, 2003).
Telomeric DNA-damage signalling in proliferating cells
When we analysed proliferating cells that were about 30 population doublings away from senescence, we routinely observed significant signatures for telomeric DNA-damage signalling, although the magnitude of signalling was considerably lower than that occurring in senescent cell populations. These findings are reminiscent of those reported in a recent study by Verdun et al (2005), where the authors postulated that functional telomeres are transiently recognised as DSBs after replication. However, as we found that quiescent cells (in the G0 phase of the cell cycle) showed the same telomere-damage pattern, the phenomenon we observed is most likely not due to transient uncapping during S-phase. Instead, it is more likely that the damage signal we observed reflected a subpopulation of cells within the proliferating cell culture undergoing early senescence. It is generally accepted that telomere-initiated senescence is a stochastic process, rather than a 'clock-based' mechanism that shortens telomeres at a defined rate (Von Zglinicki, 2003). After 87 population doublings, the majority of BJ cells are senescent; however, similar to observations made with other cell lines (Hastings et al, 2004), we found low but significant numbers of senescent BJ cells after only 60 population doublings. Senescence in young proliferating BJ cells might be caused by problems during replication of short telomeres, as we found that hTERT immortalised cells with long telomeres exhibited no detectable telomeric damage signals at all. Interestingly, proliferating BJ cells exhibited a major enrichment peak at telomere 6p (Supplementary Figure S6), but this was not observed in hTERT immortalised BJ cells or in proliferating MRC5 cells (data not shown), suggesting that telomere 6p is prone to be uncapped specifically in BJ cells in the absence of telomerase.
Concluding remarks
We have presented the first genome-wide high-resolution data about the extent of spreading of DDR factors in mammalian cells. Although we are unable to rule out the possibility of variations in the extent and distribution of other chromosomal breaks in subtelomeric regions, our findings strongly support the idea that H2AX spreading is not uniform, but is modulated in a manner suggesting that H2AX distribution or its ability to be phosphorylated is not equal between different regions of the genome. Future studies will be required to identify the underlying molecular mechanisms for these phenomena, to establish precisely how DDR chromatin spreading is controlled, and how and why there are dramatic differences in the extent of DDR factor spreading between yeast and mammalian cells.
Materials and methods Mammalian cell culture
BJ and MRC5 human primary fibroblasts and immortalised BJ-hTERT cells were grown in DMEM with 10% fetal bovine serum and PSQF at 37°C/5% CO2. Senescence was evaluated by failure to reach confluence after 4 weeks in culture from the last 1:2 passage, failure of >95% cells to incorporate BrdU after a 24-h period and expression of senescence-associated -Gal in >95% of cells. For quiescence, cells were serum starved for 3 days in DMEM/0.5%FBS/PSQF. Senescent cells were treated for 24 h with an inhibitor specific for ATM (Hickson et al, 2004) at 10 M and released into fresh medium.
Indirect immunofluorescence microscopy
Cells were grown on coverslips, fixed for 10 min on ice with ice-cold methanol/acetone. Nonspecific interactions were blocked by incubation for 60 min in PBS with 5% FBS. Fixed cells were incubated with primary antibodies overnight at 4°C, washed with PBS, incubated with Alexa Fluor secondary antibodies (Molecular Probes) for 45 min at room temperature and washed with PBS. Antibodies used for immunofluorescence were obtained from Upstate biotechnology ( H2AX mouse monoclonal) and Novus (53BP1 rabbit). Images were obtained using a Nikon Eclipse E800 with a BioRad Radiance 2100 laser set-up and BioRad LaserSharp software.
ChIP
In vivo cross-linking, chromatin purification and immunoprecipitations were as described previously (Orlando et al, 1997). The average fragment size of soluble chromatin fragments after sonication was 750 bp. Commercial antibodies used for ChIP were obtained from Upstate biotechnology ( H2AX mouse monoclonal and rabbit polyclonal antibodies) and Novus (rabbit 53BP1). Sheep antisera to MDC1 have been described in Goldberg et al (2003). Two different antibodies for each of H2AX and MDC1 were used to confirm specificity in the ChIP experiments.
Array-CGH
Whole-genome tile path arrays were prepared as described previously (Fiegler et al, 2006) and printed at the UCSF microarray facility (http://cc.ucsf.edu/microarray). For telomeric arrays, 1 kb amino-modified PCR products covering 2 Mb of telomeres 7q, 8q, 12p and 20q at 10 kb resolution were printed onto CodeLink activated slides (GE Healthcare Life Sciences) by the Wellcome Trust Sanger Institute Microarray Facility (http://www.sanger.ac.uk/Projects/Microarrays/; for details, see Supplementary Information). The custom designed oligo-array (NimbleGen Systems Inc., www.nimblegen.com) covered 3 Mb of each human chromosome end with the exception of 5 Mb of telomere 6p. A repeat masked sequence of NCBI build 36, hg18, was used to select 390 000 isothermal oligos of 50 to 75 bp spaced at a mean interval of 230 bp. Array-CGH was performed as described previously with slight modifications (Fiegler et al, 2006; for details, see Supplementary Information). For oligonucleotide arrays, amplified ChIP samples were labelled and hybridised by NimbleGen Systems Inc. (www.nimblegen.com).
Data analysis
Arrays were scanned with an Agilent scanner (Agilent Technologies, UK) and images quantified by GenePix version 6.0 software (GRI, UK). Fluorescent ratios were normalised to the median ratio of intensities of all autosomal clones on the array. For tile-path arrays, the data of the colour-reversal experiments and replicate experiments were averaged and data were plotted as the log2 ratio. For telomeric arrays, the data of colour reversal and replicate experiments were averaged and data points that were outside a confidence interval of 50% were excluded. The difference of the log2 ratio of senescent minus proliferating cells (diff log2) was calculated and plotted. For NimbleGen oligo-arrays, the data were averaged over a window of N data points (either 5 or 100). Given a window size of N, for each data point, an average was calculated including the point and N/2 data points on each side (where possible). For all figures, NCBI build 36, hg18 was used.
Staining for senescent associated -Gal activity
BJ cells were grown on coverslips and fixed in formaldehyde buffer at different population doublings between PD50 and PD87 (full senescence) and stained for senescence-associated -Gal activity at pH 6 (Dimri et al, 1995) with a senescence cell histochemical staining kit (Sigma Cat No CS0030-1KT). Coverslips were mounted on slides with DAPI mounting medium and the percentage of -Gal-positive cells was scored under a fluorescence/DIC microscope.
Real-time PCR
Real-time PCR was carried out using the SYBR green PCR system (Applied Biosystems); purified DNA samples of the ChIP fraction and the input DNA samples were amplified together with serial dilutions of genomic DNA on an ABI Prism 7000 sequence detector system (Applied Biosystems). HPLC-purified primer pairs were selected from a repeat masked sequence (NCBI build 36, hg18) and tested for their specificity. Primer pairs are listed in Supplementary data.
Telomere length measurements by Q-FISH and spectral karyotyping
Metaphases from pre-senescent BJ and MRC5 cells were prepared for Q-FISH, hybridised with a telomeric probe and analysed as described previously (Herrera et al, 1999; Samper et al, 2000; McIlrath et al, 2001). For details, see Supplementary data.
Supplementary data
Supplementary data are available at The EMBO Journal Online (http://www.embojournal.org).
Acknowledgements
We thank members of the Jackson laboratory for their suggestions and advice; S Gravel, P Huertas, K Miller and K Dry for critical reading of the manuscript; J Coates for help with tissue culture; S Polo for advice with real-time PCR; M Gilchrist for bioinformatics and help with analysis of microarray data; R Andrews for amplicon and primer design for the telomeric arrays; G Saretzki and T von Zglinicki for cell lines; P Reaper and V Smits for pilot studies and the design of telomeric arrays; and D Albertson, D Pinkel, R Davis, G Hamilton and the UCSF Comprehensive Cancer Center Microarray Core Facility for whole-genome tiling path array spotting. This work was made possible through core funding by Cancer Research UK and the Wellcome Trust, and was supported by Cancer Research UK and grant no. PA00A-111456 from the Swiss National Foundation to AM. MA Blasco's laboratory is funded by the Spanish Ministry of Education and Culture, the Regional Government of Madrid, European Union (TELOSENS FIGH-CT-2002-00217, INTACT LSHC-CT-2003-506803, ZINCAGE FOOD-CT-2003-506850, RISC-RAD FI6R-CT-2003-508842, MOL CANCER MED LSHC-CT-2004-502943) and the Josef Steiner Award 2003.
References
Bekker-Jensen S, Lukas C, Kitagawa R, Melander F, Kastan MB, Bartek J, Lukas J (2006) Spatial organization of the mammalian genome surveillance machinery in response to DNA strand breaks. J Cell Biol 173: 195–206 | Article | PubMed | ChemPort | Bekker-Jensen S, Lukas C, Melander F, Bartek J, Lukas J (2005) Dynamic assembly and sustained retention of 53BP1 at the sites of DNA damage are controlled by Mdc1/NFBD1. J Cell Biol 170: 201–211 | Article | PubMed | ISI | ChemPort | Bewersdorf J, Bennett BT, Knight KL (2006) H2AX chromatin structures and their response to DNA damage revealed by 4Pi microscopy. Proc Natl Acad Sci USA 103: 18137–18142 | Article | PubMed | ChemPort | Blasco MA (2005) Telomeres and human disease: ageing, cancer and beyond. Nat Rev Genet 6: 611–622 | Article | PubMed | ISI | ChemPort | Botuyan MV, Lee J, Ward IM, Kim JE, Thompson JR, Chen J, Mer G (2006) Structural basis for the methylation state-specific recognition of histone H4-K20 by 53BP1 and Crb2 in DNA repair. Cell 127: 1361–1373 | Article | PubMed | ChemPort | Celeste A, Petersen S, Romanienko PJ, Fernandez-Capetillo O, Chen HT, Sedelnikova OA, Reina-San-Martin B, Coppola V, Meffre E, Difilippantonio MJ, Redon C, Pilch DR, Olaru A, Eckhaus M, Camerini-Otero RD, Tessarollo L, Livak F, Manova K, Bonner WM, Nussenzweig MC, Nussenzweig A (2002) Genomic instability in mice lacking histone H2AX. Science 296: 922–927 | Article | PubMed | ISI | ChemPort | d'Adda di Fagagna F, Reaper PM, Clay-Farrace L, Fiegler H, Carr P, Von Zglinicki T, Saretzki G, Carter NP, Jackson SP (2003) A DNA damage checkpoint response in telomere-initiated senescence. Nature 426: 194–198 | Article | D'Adda Di Fagagna F, Teo SH, Jackson SP (2004) Functional links between telomeres and proteins of the DNA-damage response. Genes Dev 18: 1781–1799 | Article | PubMed | de Lange T (2005) Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev 19: 2100–2110 | Article | PubMed | ISI | ChemPort | Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medrano EE, Linskens M, Rubelj I, Pereira-Smith O, Peacocke M, Campisi J (1995) A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 92: 9363–9367 | Article | PubMed | ChemPort | Falck J, Coates J, Jackson SP (2005) Conserved modes of recruitment of ATM, ATR and DNA-PKcs to sites of DNA damage. Nature 434: 605–611 | Article | PubMed | ISI | ChemPort | Fernandez-Capetillo O, Celeste A, Nussenzweig A (2003) Focusing on foci: H2AX and the recruitment of DNA-damage response factors. Cell Cycle 2: 426–427 | PubMed | ChemPort | Fernandez-Capetillo O, Lee A, Nussenzweig M, Nussenzweig A (2004) H2AX: the histone guardian of the genome. DNA Repair (Amst) 3: 959–967 | Article | PubMed | ChemPort | Fiegler H, Redon R, Andrews D, Scott C, Andrews R, Carder C, Clark R, Dovey O, Ellis P, Feuk L, French L, Hunt P, Kalaitzopoulos D, Larkin J, Montgomery L, Perry GH, Plumb BW, Porter K, Rigby RE, Rigler D, Valsesia A, Langford C, Humphray SJ, Scherer SW, Lee C, Hurles ME, Carter NP (2006) Accurate and reliable high-throughput detection of copy number variation in the human genome. Genome Res 16: 1566–1574 | Article | PubMed | ChemPort | Goldberg M, Stucki M, Falck J, D'Amours D, Rahman D, Pappin D, Bartek J, Jackson SP (2003) MDC1 is required for the intra-S-phase DNA damage checkpoint. Nature 421: 952–956 | Article | PubMed | ISI | ChemPort | Gonzalo S, Jaco I, Fraga MF, Chen T, Li E, Esteller M, Blasco MA (2006) DNA methyltransferases control telomere length and telomere recombination in mammalian cells. Nat Cell Biol 8: 416–424 | Article | PubMed | ChemPort | Graakjaer J, Bischoff C, Korsholm L, Holstebroe S, Vach W, Bohr VA, Christensen K, Kolvraa S (2003) The pattern of chromosome-specific variations in telomere length in humans is determined by inherited, telomere-near factors and is maintained throughout life. Mech Ageing Dev 124: 629–640 | Article | PubMed | ChemPort | Hastings R, Qureshi M, Verma R, Lacy PS, Williams B (2004) Telomere attrition and accumulation of senescent cells in cultured human endothelial cells. Cell Prolif 37: 317–324 | Article | PubMed | ChemPort | Hayflick L, Moorhead PS (1961) The serial cultivation of human diploid cell strains. Exp Cell Res 25: 585–621 | Article | ISI | Herbig U, Jobling WA, Chen BP, Chen DJ, Sedivy JM (2004) Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21(CIP1), but Not p16(INK4a). Mol Cell 14: 501–513 | Article | PubMed | ISI | ChemPort | Herrera E, Samper E, Martin-Caballero J, Flores JM, Lee HW, Blasco MA (1999) Disease states associated with telomerase deficiency appear earlier in mice with short telomeres. EMBO J 18: 2950–2960 | Article | PubMed | ISI | ChemPort | Hickson I, Zhao Y, Richardson CJ, Green SJ, Martin NM, Orr AI, Reaper PM, Jackson SP, Curtin NJ, Smith GC (2004) Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM. Cancer Res 64: 9152–9159 | Article | PubMed | ISI | ChemPort | Hockemeyer D, Sfeir AJ, Shay JW, Wright WE, de Lange T (2005) POT1 protects telomeres from a transient DNA damage response and determines how human chromosomes end. EMBO J 24: 2667–2678 | Article | PubMed | ISI | ChemPort | Huyen Y, Zgheib O, Ditullio Jr RA, Gorgoulis VG, Zacharatos P, Petty TJ, Sheston EA, Mellert HS, Stavridi ES, Halazonetis TD (2004) Methylated lysine 79 of histone H3 targets 53BP1 to DNA double-strand breaks. Nature 432: 406–411 | Article | PubMed | ISI | ChemPort | Khanna KK, Jackson SP (2001) DNA double-strand breaks: signaling, repair and the cancer connection. Nat Genet 27: 247–254 | Article | PubMed | ISI | ChemPort | Londono-Vallejo JA, DerSarkissian H, Cazes L, Thomas G (2001) Differences in telomere length between homologous chromosomes in humans. Nucleic Acids Res 29: 3164–3171 | Article | PubMed | ChemPort | Lorenz M, Saretzki G, Sitte N, Metzkow S, von Zglinicki T (2001) BJ fibroblasts display high antioxidant capacity and slow telomere shortening independent of hTERT transfection. Free Radic Biol Med 31: 824–831 | Article | PubMed | ISI | ChemPort | Lou Z, Minter-Dykhouse K, Franco S, Gostissa M, Rivera MA, Celeste A, Manis JP, van Deursen J, Nussenzweig A, Paull TT, Alt FW, Chen J (2006) MDC1 maintains genomic stability by participating in the amplification of ATM-dependent DNA damage signals. Mol Cell 21: 187–200 | Article | PubMed | ChemPort | Lukas C, Melander F, Stucki M, Falck J, Bekker-Jensen S, Goldberg M, Lerenthal Y, Jackson SP, Bartek J, Lukas J (2004) Mdc1 couples DNA double-strand break recognition by Nbs1 with its H2AX-dependent chromatin retention. EMBO J 23: 2674–2683 | Article | PubMed | ISI | ChemPort | Martens UM, Chavez EA, Poon SS, Schmoor C, Lansdorp PM (2000) Accumulation of short telomeres in human fibroblasts prior to replicative senescence. Exp Cell Res 256: 291–299 | Article | PubMed | ISI | ChemPort | McIlrath J, Bouffler SD, Samper E, Cuthbert A, Wojcik A, Szumiel I, Bryant PE, Riches AC, Thompson A, Blasco MA, Newbold RF, Slijepcevic P (2001) Telomere length abnormalities in mammalian radiosensitive cells. Cancer Res 61: 912–915 | PubMed | ISI | ChemPort | Orlando V, Strutt H, Paro R (1997) Analysis of chromatin structure by in vivo formaldehyde cross-linking. Methods 11: 205–214 | Article | PubMed | ISI | ChemPort | Pilch DR, Sedelnikova OA, Redon C, Celeste A, Nussenzweig A, Bonner WM (2003) Characteristics of gamma-H2AX foci at DNA double-strand breaks sites. Biochem Cell Biol 81: 123–129 | Article | PubMed | ISI | ChemPort | Raisner RM, Hartley PD, Meneghini MD, Bao MZ, Liu CL, Schreiber SL, Rando OJ, Madhani HD (2005) Histone variant H2A.Z marks the 5' ends of both active and inactive genes in euchromatin. Cell 123: 233–248 | Article | PubMed | ISI | ChemPort | Rogakou EP, Boon C, Redon C, Bonner WM (1999) Megabase chromatin domains involved in DNA double-strand breaks in vivo. J Cell Biol 146: 905–916 | Article | PubMed | ISI | ChemPort | Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM (1998) DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem 273: 5858–5868 | Article | |